IntrinsicIntrinsic
← All summaries

CSP INC /MA/

CSPI
Financials & Chart →

Business Summary

CSP Inc. operates in two segments: Technology Solutions (TS) and High Performance Products (HPP). The TS segment, through its wholly-owned Modcomp, Inc. subsidiary, operates in the United States and the United Kingdom, reselling third-party computer hardware and software as a value-added reseller and delivering professional services for complex IT solutions including advanced security, unified communications, wireless and mobility, data center solutions, and network solutions, as well as managed IT services primarily serving the small and mid-sized business market. The HPP segment generates revenue from three product lines: the ARIA Software-Defined Security cybersecurity solution offered to commercial, OEM, and government customers; the Myricom network adapters and related software for commercial, government, and OEM customers; and the legacy Multicomputer product portfolio for digital signal processing applications within the defense markets. The ARIA SDS solution is a software portfolio comprised of three products: ARIA Packet Intelligence software, ARIA Advanced Detection and Response solution, and ARIA Zero Trust PROTECT, which was introduced in July of 2023 and designed to stop sophisticated attacks on critical infrastructure applications. The ARIA portfolio is of value to regulated industries such as manufacturing, pharmaceuticals, financial services, energy production, utilities, transportation, and healthcare due to the rise of critical infrastructure regulations. The Myricom SmartNIC adapters (ARC Series and Secure Intelligent Adapters) are optimized for markets requiring high-bandwidth and low-latency including packet capture, financial transactions, machine vision, and network security, though the ARC series has reached end of life due to ASIC supplier problems. Multicomputer products for DSP applications are no longer actively developed but will continue to be sold into established programs through fiscal year 2025 and supported for several years via repair services.

Primary competitors in the TS segment include other VARs ranging from small companies to large enterprises such as CDW, PC Connection, Insight, Presidio, Dimension Data, and Computacenter Limited, as well as manufacturers like Cisco Systems, IBM, HPE, and EMC (now part of Dell). In the network management, security, and storage systems integration services business, competitors include HP/EDS, IBM, and Cap Gemini. Favorable competitive factors for the TS segment include procurement capability, product diversity enabling delivery of complete and custom solutions, strength of key business relationships with major IT OEMs, ability to meet unique needs of SMB and LEB markets, strong knowledge of IT products, and ability to provide managed services through the network operations center and professional IT services. Unfavorable competitive factors include low name recognition, limited geographic coverage, and pricing. In the HPP segment, CSPi's competition in the cybersecurity space comes primarily from large traditional security vendors like Palo Alto, VMware, and security services providers like Arctic Wolf.

The TS segment generates product revenues by reselling third-party computer hardware and software as a value-added reseller and generates service revenues through delivery of professional services for complex IT solutions, including advanced security, unified communications and collaboration, wireless and mobility, data center solutions, and network solutions, as well as managed IT services that primarily serve the SMB market. Third-party products and professional services are marketed and sold through the Company's direct sales force into a variety of vertical markets including automotive, defense, healthcare, education, federal, state and local government, and maritime. The HPP segment derives revenue from license sales of software platform components, support packages, and any required supporting services, with software licenses, support packages, and supporting services renewable on a recurring basis. The ARIA SDS and ADR solution is targeted at organizations needing additional functionality from current cybersecurity solutions to find and stop attacks while reducing operating costs, and is primarily offered through direct sales channel, though with ARIA AZT PROTECT's introduction the Company has begun to add channel partners such as independent resellers. OEM vendors in the cybersecurity market can benefit from integrating ARIA applications, and MSSPs require simple yet differentiated solutions that can be deployed across customer bases.

For the fiscal year ended September 30, 2025, the TS segment generated total sales of $56.808 million , representing 97% of total Company sales, compared to $51.065 million and 92% in the prior year. The TS segment revenue increased by approximately $5.7 million consisting of an increase of $5.5 million in the U.S. division combined with an increase of $0.2 million in the U.K. division. TS segment products revenue increased by $3.0 million during the period, resulting from a $2.8 million increase in the U.S. division combined with an increase of $0.2 million in the U.K. division. TS segment services revenue increased by $2.7 million as compared to the prior year, entirely in the U.S. division due to an increase of $1.3 million in third-party maintenance revenue, an increase of $1.1 million in internal and third party services, and an increase of $0.3 million in managed services. The TS segment gross margin as a percentage of revenue decreased to 31% in fiscal year 2025 from 32% in fiscal year 2024. TS segment product gross margin as a percentage of revenue decreased 2% for fiscal year 2025 compared to the prior year due to higher volume of sales to certain customers with lower margins. TS segment service gross margin as a percentage of revenue remained flat at 59% in fiscal year 2025. The gross backlog of customer orders and contracts for the TS segment was approximately $7.1 million as of September 30, 2025 compared to $4.9 million as of September 30, 2024.

For the fiscal year ended September 30, 2025, the HPP segment generated total sales of $1.922 million , representing 3% of total Company sales, compared to $4.154 million and 8% in the prior year. The HPP segment revenue decreased by approximately $2.2 million or 54% . The decrease in HPP products revenue of $2.1 million was primarily the result of decreased ARIA AZT revenue of $1.7 million combined with decreased Myricom revenue of $0.4 million . The ARIA revenue decrease was due to one large nonrecurring ARIA AZT software license sale of $2.0 million in the prior year, partially offset by increased total ARIA AZT software license sales of $0.3 million . The decreased Myricom revenue was primarily due to one large nonrecurring transaction in the prior year. The decrease in HPP services revenue of approximately $0.1 million was primarily the result of a $0.3 million decrease in repairs revenue and a $0.2 million decrease in royalty revenues on high-speed processing boards related to the E2D program, partially offset by an increase in Multicomputer revenue of $0.2 million and increased ARIA revenue of $0.2 million . The overall HPP segment gross margin as a percentage of revenue decreased to 46% in fiscal year 2025 from 65% in fiscal year 2024. The gross margin as a percentage of sales from products decreased 26% primarily due to a nonrecurring prior year large ARIA AZT software license sale which was nearly all gross margin. The gross margin as a percentage of sales from services decreased 9% primarily due to decreased Multicomputer royalty revenues, which is nearly all gross margin and recorded as service revenue. The gross backlog of customer orders and contracts in the HPP segment was $1.0 million as of September 30, 2025 as compared to $0.8 million as of September 30, 2024.

During the fiscal year ended September 30, 2025, the Company repurchased 19,500 shares of common stock at an average price of $11.98 per share under the stock repurchase program authorized on February 8, 2011, which authorizes the repurchase of up to 500 thousand additional shares and does not expire. As of September 30, 2025, 272,354 shares remained available for repurchase under the plan. The Company paid cash dividends of $0.030 per share in each of the four quarters of fiscal year 2025, totaling $1.188 million in dividends paid. In October 2024, in connection with the planned termination of the defined benefit pension plan in the U.K., the Company paid 8.5 million British pounds to enter into a buy-in contract, with the expected timeframe of the buy-in contract turning into a buy-out contract within fiscal year 2026. The Company maintained a line of credit with a capacity of up to $15.0 million for inventory accessible to both segments, with $14.1 million available as of September 30, 2025. The last note payable was paid in full in fiscal year 2025 of $0.4 million and no notes remain outstanding as of September 30, 2025. There is a total of $5.3 million due to vendors with financing agreements outstanding as of September 30, 2025, including $3.5 million payments to be made in the next 12 months. There is a total of $16.3 million due to the Company of customer financing agreements outstanding as of September 30, 2025, including $9.9 million to be received in the next 12 months. The Company's research and development expenses were $3.3 million for fiscal year 2025 compared to $3.0 million for fiscal year 2024.

Total revenue increased by approximately $3.5 million , or 6% , to $58.730 million for the fiscal year ended September 30, 2025 compared to $55.219 million for the fiscal year ended September 30, 2024. Gross profit margin percentage decreased to 32% for fiscal year 2025 compared to 34% for fiscal year 2024. The Company generated an operating loss of $(3.109) million for fiscal year 2025 as compared to an operating loss of $(1.872) million for fiscal year 2024. Other income, net was consistent at approximately $1.5 million for both fiscal years. The Company recorded an income tax benefit of $(1.570) million , which reflected an effective tax rate of 94.5% , for fiscal year 2025 compared to an income tax benefit of $(0.093) million , which reflected an effective tax rate of 22.2% for fiscal year 2024. Net loss was $(0.091) million for fiscal year 2025 compared to $(0.326) million for fiscal year 2024. Cash and cash equivalents decreased by $3.2 million to $27.418 million as of September 30, 2025 from $30.585 million as of September 30, 2024. Net cash provided by operating activities was $2.268 million for fiscal year 2025 compared to $4.213 million for the prior year.

Business Outlook

The Company's focus for fiscal year 2026 and beyond is to expand from initial successes more broadly into the manufacturing market and its various sub segments. The ARIA AZT PROTECT product is believed to be well suited to address a critical security gap in the energy/utility market, though sales cycles can be up to 1 year . The Company expects to continue to make investments related to the development of new cybersecurity software applications. The ARIA AZT PROTECT product was designed to fill a gap in the market by stopping the most sophisticated attacks used to attack critical infrastructure applications before harm can be done, and the product is deployed and generating revenue from its initial contracts. The Company has begun selling its unique solution into MSSPs that want to offer a lower cost, more effective service at detecting today's widening range of cyber-attacks. The Company expects to continue to make investments related to the development of new cybersecurity software applications.

The filing does not contain a separate dedicated paragraph on margin and cost outlook beyond the historical margin trends and the expectation that spending as a percent of revenues may fluctuate in the future due to the commitment to invest in R&D.

The Company expects to continue to make investments related to the development of new cybersecurity software applications. The Company's research and development expenses were $3.3 million for fiscal year 2025 compared to $3.0 million for fiscal year 2024. The Company expects to continue to make investments related to the development of new cybersecurity software applications. The Company's focus for fiscal year 2026 and beyond is to expand from initial successes more broadly into the manufacturing market and its various sub segments. The ARIA AZT PROTECT product is believed to be well suited to address a critical security gap in the energy/utility market, though sales cycles can be up to 1 year .

The Company expects to continue to make investments related to the development of new cybersecurity software applications. Research and development expenses were $3.3 million for fiscal year 2025 compared to $3.0 million for fiscal year 2024. The Company's line of credit has a capacity of up to $15.0 million for inventory accessible to both segments. The Company paid cash dividends of $0.030 per share in each of the four quarters of fiscal year 2025, totaling $1.188 million in dividends paid. The Company repurchased 19,500 shares of common stock at an average price of $11.98 per share during the three months ended September 30, 2025, and as of September 30, 2025, 272,354 shares remained available for repurchase under the plan authorized on February 8, 2011, which authorizes the repurchase of up to 500 thousand additional shares and does not expire.

The ARC series of Myricom SmartNIC adapters has reached end of life due to ASIC supplier problems which will significantly reduce its contribution to the HPP line of business. The revenue from Multicomputer products for DSP applications, as a percentage of overall Company revenue, is expected to continue to decline over time. The Company's international operation is subject to risks including changes in applicable laws and regulatory requirements, export and import restrictions, export controls relating to technology, tariffs and other trade barriers, longer payment cycles, problems in collecting accounts receivable, political instability, fluctuations in currency exchange rates, expatriation controls and potential adverse tax consequences. Beginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others, and the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962 into imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. These tariffs do not currently include software, services, intangibles, and other digital services, but the Company cannot predict future trade policy or tariffs.

The global economy has been negatively impacted by the military conflict between Russia and Ukraine, and although the Company does not have significant customers or suppliers in Russia or Ukraine, it does have customers and suppliers in surrounding regions which may be affected. Further escalation of Russian-Ukraine military conflict and geopolitical tensions could result in cyber attacks, supply disruptions, lower consumer demand, and changes to foreign exchange rates and financial markets. The global economy has also been negatively impacted by the military conflict between Israel and Hamas, and although the Company does not have significant customers or suppliers in the Middle East region, it does have customers and suppliers in surrounding regions which may be affected. Violation of the peace process may lead to renewed military conflict and/or escalation of the Israel and Hamas conflict and geopolitical tensions, which could result in cyber attacks, supply disruptions, lower consumer demand, and changes to foreign exchange rates and financial markets.

Risk Factors

The Company depends on a small number of customers for a significant portion of its revenue, and the loss of any customer could significantly affect the business, though for fiscal years 2025 and 2024 no one customer accounted for 10% or more of total revenues . The Company has made significant investments in ARIA cyber security products and services that may not achieve expected returns, and commercial success depends on many factors including innovativeness, developer support, and effective distribution and marketing. The ARC series of Myricom SmartNIC adapters has reached end of life due to ASIC supplier problems which will significantly reduce its contribution to the HPP line of business. The Company's international operations are subject to risks including changes in laws, export controls, tariffs, and currency fluctuations, with foreign-based revenue representing 10% and 12% of total revenue for fiscal years 2025 and 2024 respectively. Beginning in the second quarter of 2025, new U.S. Tariffs were announced including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others, and the U.S. Department of Commerce has initiated an investigation under Section 232 into imports of semiconductors and their derivative products, which could materially adversely affect the Company's business, results of operations, financial condition and stock price.

Management Priorities

Management's discussion and analysis of financial condition and results of operations notes that revenue increased by approximately $3.5 million , or 6% , to $58.7 million for fiscal year 2025 compared to $55.2 million for fiscal year 2024, while gross profit margin percentage decreased to 32% from 34% . The Company generated an operating loss of $(3.1) million for fiscal year 2025 as compared to an operating loss of $(1.9) million for fiscal year 2024. Other income, net was consistent at approximately $1.5 million for both fiscal years. The Company recorded an income tax benefit of $(1.6) million , which reflected an effective tax rate of 94.5% , for fiscal year 2025 compared to an income tax benefit of $(0.1) million , which reflected an effective tax rate of 22.2% for fiscal year 2024. Management states that based on current plans and business conditions, the Company's available cash and cash equivalents, cash generated from operations, and availability on the line of credit will be sufficient to provide for working capital and capital expenditure requirements for at least 12 months from the date of the filing. The strategic priorities emphasized include expanding from initial successes more broadly into the manufacturing market and its various sub segments for fiscal year 2026 and beyond, continuing to make investments related to the development of new cybersecurity software applications, and focusing on the ARIA AZT PROTECT product which is believed to be well suited to address a critical security gap in the energy/utility market.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Sales Information by Industry Segment
  2. [2] Item 1, Business — Sales Information by Industry Segment
  3. [3] Item 1, Business — Sales Information by Industry Segment
  4. [4] Item 1, Business — Sales Information by Industry Segment
  5. [5] Item 7, MD&A — Revenues
  6. [6] Item 7, MD&A — Revenues
  7. [7] Item 7, MD&A — Revenues
  8. [8] Item 7, MD&A — Revenues
  9. [9] Item 7, MD&A — Revenues
  10. [10] Item 7, MD&A — Revenues
  11. [11] Item 7, MD&A — Revenues
  12. [12] Item 7, MD&A — Revenues
  13. [13] Item 7, MD&A — Revenues
  14. [14] Item 7, MD&A — Revenues
  15. [15] Item 7, MD&A — Gross Margins
  16. [16] Item 7, MD&A — Gross Margins
  17. [17] Item 7, MD&A — Gross Margins
  18. [18] Item 7, MD&A — Gross Margins
  19. [19] Item 1, Business — Backlog (TS)
  20. [20] Item 1, Business — Backlog (TS)
  21. [21] Item 1, Business — Sales Information by Industry Segment
  22. [22] Item 1, Business — Sales Information by Industry Segment
  23. [23] Item 1, Business — Sales Information by Industry Segment
  24. [24] Item 1, Business — Sales Information by Industry Segment
  25. [25] Item 7, MD&A — Revenues
  26. [26] Item 7, MD&A — Revenues
  27. [27] Item 7, MD&A — Revenues
  28. [28] Item 7, MD&A — Revenues
  29. [29] Item 7, MD&A — Revenues
  30. [30] Item 7, MD&A — Revenues
  31. [31] Item 7, MD&A — Revenues
  32. [32] Item 7, MD&A — Revenues
  33. [33] Item 7, MD&A — Revenues
  34. [34] Item 7, MD&A — Revenues
  35. [35] Item 7, MD&A — Revenues
  36. [36] Item 7, MD&A — Revenues
  37. [37] Item 7, MD&A — Gross Margins
  38. [38] Item 7, MD&A — Gross Margins
  39. [39] Item 7, MD&A — Gross Margins
  40. [40] Item 7, MD&A — Gross Margins
  41. [41] Item 1, Business — Backlog (HPP)
  42. [42] Item 1, Business — Backlog (HPP)
  43. [43] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  44. [44] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  45. [45] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  46. [46] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  47. [47] Item 5, Market for Registrant's Common Equity — Dividends
  48. [48] Item 8, Consolidated Statements of Cash Flows
  49. [49] Item 7, MD&A — Other Liquidity and Capital Resources Items
  50. [50] Item 7, MD&A — Other Liquidity and Capital Resources Items
  51. [51] Item 7, MD&A — Other Liquidity and Capital Resources Items
  52. [52] Item 7, MD&A — Other Liquidity and Capital Resources Items
  53. [53] Item 7, MD&A — Other Liquidity and Capital Resources Items
  54. [54] Item 7, MD&A — Other Liquidity and Capital Resources Items
  55. [55] Item 7, MD&A — Other Liquidity and Capital Resources Items
  56. [56] Item 7, MD&A — Other Liquidity and Capital Resources Items
  57. [57] Item 7, MD&A — Research and Development Expenses
  58. [58] Item 7, MD&A — Research and Development Expenses
  59. [59] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  60. [60] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  61. [61] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  62. [62] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  63. [63] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  64. [64] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  65. [65] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  66. [66] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  67. [67] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  68. [68] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  69. [69] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  70. [70] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  71. [71] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  72. [72] Item 8, Consolidated Statements of Operations
  73. [73] Item 8, Consolidated Statements of Operations
  74. [74] Item 7, MD&A — Cash Flows
  75. [75] Item 8, Consolidated Balance Sheets
  76. [76] Item 8, Consolidated Balance Sheets
  77. [77] Item 8, Consolidated Statements of Cash Flows
  78. [78] Item 8, Consolidated Statements of Cash Flows
  79. [79] Item 1, Business — Energy/Utility Market
  80. [80] Item 7, MD&A — Research and Development Expenses
  81. [81] Item 7, MD&A — Research and Development Expenses
  82. [82] Item 1, Business — Energy/Utility Market
  83. [83] Item 7, MD&A — Research and Development Expenses
  84. [84] Item 7, MD&A — Research and Development Expenses
  85. [85] Item 7, MD&A — Other Liquidity and Capital Resources Items
  86. [86] Item 5, Market for Registrant's Common Equity — Dividends
  87. [87] Item 8, Consolidated Statements of Cash Flows
  88. [88] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  89. [89] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  90. [90] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  91. [91] Item 5, Market for Registrant's Common Equity — Purchases of equity securities
  92. [92] Item 1A, Risk Factors — We depend on a small number of customers
  93. [93] Item 1A, Risk Factors — Our international operation is subject to a number of risks
  94. [94] Item 1A, Risk Factors — Our international operation is subject to a number of risks
  95. [95] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  96. [96] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  97. [97] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  98. [98] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  99. [99] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  100. [100] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  101. [101] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  102. [102] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  103. [103] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  104. [104] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  105. [105] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  106. [106] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  107. [107] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  108. [108] Item 8, Consolidated Statements of Operations
  109. [109] Item 8, Consolidated Statements of Operations
  110. [110] Item 8, Consolidated Statements of Operations
  111. [111] Item 8, Consolidated Statements of Operations
  112. [112] Item 8, Consolidated Statements of Operations
  113. [113] Item 8, Consolidated Statements of Operations
  114. [114] Item 8, Consolidated Statements of Operations
  115. [115] Item 8, Consolidated Statements of Operations
  116. [116] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  117. [117] Item 7, MD&A — Overview of Fiscal Year 2025 Results of Operations
  118. [118] Item 8, Consolidated Statements of Operations
  119. [119] Item 8, Consolidated Statements of Operations
  120. [120] Item 8, Consolidated Statements of Operations
  121. [121] Item 8, Consolidated Statements of Operations
  122. [122] Item 8, Consolidated Statements of Operations
  123. [123] Item 8, Consolidated Statements of Operations
  124. [124] Item 8, Consolidated Balance Sheets
  125. [125] Item 8, Consolidated Balance Sheets
  126. [126] Item 1, Business — Sales Information by Industry Segment
  127. [127] Item 1, Business — Sales Information by Industry Segment
  128. [128] Item 1, Business — Sales Information by Industry Segment
  129. [129] Item 1, Business — Sales Information by Industry Segment
  130. [130] Item 7, MD&A — Income Taxes
  131. [131] Item 7, MD&A — Income Taxes
  132. [132] Item 7, MD&A — Income Taxes

Analysis on 6/21/2026